From: Subretinal adipose tissue-derived mesenchymal stem cell implantation in advanced stage retinitis pigmentosa: a phase I clinical safety study
Surface markers
Positive percentage (%) (n = 11)
CD45
0.5 ± 0.3
CD34
CD11b
CD19
CD105
99.73 ± 0.1
CD73
99.03 ± 0.7
CD90
94.83 ± 0.5
CD44
99.46 ± 0.6
HLA-DR